Literature DB >> 9858339

Signaling of de-adhesion in cellular regulation and motility.

J A Greenwood1, J E Murphy-Ullrich.   

Abstract

Adhesion is a process that can be divided into three separate stages: (1) cell attachment, (2) cell spreading, and (3) the formation of focal adhesions and stress fibers. With each stage the adhesive strength of the cell increases. De-adhesion can be defined as the process involving the transition of the cell from a strongly adherent state, characterized by focal adhesions and stress fibers, to a state of intermediate adherence, represented by a cell that is spread, but that lacks stress fibers terminating at adhesion plaques. We propose that this modification of the structural link between the actin cytoskeleton and the extracellular matrix results in a more malleable cellular state conducive for dynamic processes such as cytokinesis, mitogenesis, and motility. Anti-adhesive proteins, including thrombospondin, tenascin, and SPARC, rapidly signal de-adhesion, potentially mediating proliferation and migration during development and wound healing. Intracellular signaling molecules involved in the regulation of de-adhesion are only beginning to be identified. Interestingly, many of the same signaling proteins recognized to play important roles during the process of adhesion have also been found to act during de-adhesion. Characterization of the precise mechanisms by which these signals modulate adhesive structures and the cytoskeleton will further our understanding of the regulation of adhesive strength and its function in cellular physiology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9858339     DOI: 10.1002/(SICI)1097-0029(19981201)43:5<420::AID-JEMT8>3.0.CO;2-B

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  23 in total

Review 1.  The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

Authors:  J E Murphy-Ullrich
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Epithelial contact guidance on well-defined micro- and nanostructured substrates.

Authors:  Ana I Teixeira; George A Abrams; Paul J Bertics; Christopher J Murphy; Paul F Nealey
Journal:  J Cell Sci       Date:  2003-05-15       Impact factor: 5.285

Review 3.  The stereotypical molecular cascade in neovascular age-related macular degeneration: the role of dynamic reciprocity.

Authors:  D Kent
Journal:  Eye (Lond)       Date:  2015-07-31       Impact factor: 3.775

Review 4.  LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies.

Authors:  Anna P Lillis; Lauren B Van Duyn; Joanne E Murphy-Ullrich; Dudley K Strickland
Journal:  Physiol Rev       Date:  2008-07       Impact factor: 37.312

5.  Dual sources of vitronectin in the human lower urinary tract: synthesis by urothelium vs. extravasation from the bloodstream.

Authors:  Dianzhong Zhang; Amber E Hudson; Catherine F Delostrinos; Nicole Carmean; Rocky Eastman; Bryson Hicks; Robert E Hurst; James A Bassuk
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

Review 6.  Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms.

Authors:  Mariya T Sweetwyne; Joanne E Murphy-Ullrich
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

7.  SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.

Authors:  S A Rempel; W A Golembieski; J L Fisher; M Maile; A Nakeff
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 8.  Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.

Authors:  Sharmila Masli; Nader Sheibani; Claus Cursiefen; James Zieske
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

9.  cDNA array analysis of SPARC-modulated changes in glioma gene expression.

Authors:  William A Golembieski; Sandra A Rempel
Journal:  J Neurooncol       Date:  2002-12       Impact factor: 4.130

10.  SPARC accelerates disease progression in experimental crescentic glomerulonephritis.

Authors:  Amy N Sussman; Tong Sun; Ronald M Krofft; Raghu V Durvasula
Journal:  Am J Pathol       Date:  2009-03-26       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.